Last Price$20.72.1%
Market Cap$972.8M
31,083.9%
Industry median - (127.6%)
5Y Historical average - (1,481.4%)
31,074.8%
Industry median - (132.7%)
5Y Historical average - (1,489.2%)
(28.7%)
Industry median - (50.7%)
5Y Historical average - 3.3%
(35.7%)
Industry median - (51.1%)
5Y Historical average - (42.8%)
ELVN Capital Allocation Rating
ELVN Capital Allocation rating
6.2
ELVN Capital Allocation rating performance
ELVN Capital Allocation metrics
Annual
Quarterly
LTM
Industry Median
5Y Historical Average
Benchmark
Competing with ELVN Capital Allocation
Overview
Ratings
Intrinsic Value
Valuation
Growth
Profitability
Health
Capital allocation
Momentum
Earnings
Dividends
Company name | Market Cap | Capital Allocation score | ROIC | ROIC - WACC | CROIC | ROE | ROCE | Shares count growth | Shareholder yield |
$972.8M | 6.2 | 31,083.9% | 31,074.8% | 20,126.0% | (28.7%) | (35.7%) | 17.6% | N/A | |
$124.8B | 4.8 | (15.0%) | (22.6%) | (11.5%) | (3.3%) | (5.5%) | 0.1% | 1.3% | |
$77.0B | 6.0 | 25.7% | 18.1% | 25.3% | 13.7% | 10.3% | 1.4% | 4.1% | |
$34.4B | 4.2 | (41.3%) | N/A | (24.0%) | (4.8%) | (8.5%) | 2.2% | 0.0% | |
$30.7B | 3.9 | (7.2%) | (14.8%) | (4.0%) | (559.4%) | (2.6%) | 2.4% | 0.0% | |
$24.0B | 4.7 | (37.8%) | (45.6%) | (6.7%) | (3.5%) | (6.5%) | 0.8% | 0.0% | |
$14.5B | 5.5 | 14.5% | 9.6% | 37.0% | 12.9% | 6.4% | (2.8%) | 3.6% | |
$13.8B | 7.3 | 65.4% | 57.7% | 68.4% | 19.1% | 16.0% | (5.1%) | 7.3% | |
$13.4B | 6.2 | 11.0% | 3.5% | 15.1% | 7.7% | 5.5% | 1.0% | 0.5% | |
$13.3B | 4.5 | (3,335.4%) | (3,343.2%) | (2,216.2%) | (53.5%) | (51.1%) | 3.6% | 0.0% | |
$1,846.9M | 4.3 | (43.2%) | (47.6%) | (43.3%) | (25.3%) | (27.4%) | 1.2% | 0.0% |
FAQ
What is the Enliven Therapeutics, Inc. (ELVN) ROIC (Return on Invested Capital)?
The Enliven Therapeutics, Inc. (ELVN) ROIC is 31,083.9%, compared to the industry median of ((127.6%)) and the 5-year historical average of (1,481.4%).
What is the Enliven Therapeutics, Inc. (ELVN) ROIC minus WACC (Weighted Average Cost of Capital)?
The Enliven Therapeutics, Inc. (ELVN) ROIC minus WACC is 31,074.8%, compared to the industry median of ((132.7%)) and the 5-year historical average of (1,489.2%).
What is the Enliven Therapeutics, Inc. (ELVN) ROE (Return on Equity)?
The Enliven Therapeutics, Inc. (ELVN) ROE is (28.7%), compared to the industry median of ((50.7%)) and the 5-year historical average of 3.3%.
What is the Enliven Therapeutics, Inc. (ELVN) ROCE (Return on Capital Employed)?
The Enliven Therapeutics, Inc. (ELVN) ROCE is (35.7%), compared to the industry median of ((51.1%)) and the 5-year historical average of (42.8%).